Shattuck Labs is a biotechnology company that provides novel class biologic medicines for the treatment of cancer and autoimmune disease.
Shattuck Labs has raised $75.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in June 2026.
Shattuck Labs's investors include Janus Henderson Investors, Adage Capital Management, OrbiMed, Hatteras Venture Partners, Redmile Group.
Shattuck Labs is headquartered in Austin, United States.
Shattuck Labs is a biotechnology company that provides novel class biologic medicines for the treatment of cancer and autoimmune disease.
Shattuck Labs is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Shattuck Labs — Funding & Investors." VCBacked, June 10, 2026, https://www.vcbacked.co/company/shattuck-labs. Accessed August 14, 2026.
VCBacked. (2026). Shattuck Labs — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/shattuck-labs
{{cite web |title=Shattuck Labs — Funding & Investors |url=https://www.vcbacked.co/company/shattuck-labs |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated